NEW YORK, Nov. 16 - Celera Genomics’ acquisition of Axys Pharmaceuticals was formally approved by the US Securities and Exchange on Friday, Celera said. The transaction will be put to bed at the close of business in California on Friday and from then on Axys will do business under the Celera name.


To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Parabon NanoLabs is partnering with law enforcement to use genetic genealogy approaches to solve cold cases, Buzzfeed News reports.

A Columbia University-led team used emergency contact information from medical records to create family trees and estimate disease heritability.

In Science this week: ancient Southeast Asian genomes provide insight on human migration, and more.

NPR says a new report recommends that former research chimpanzees should be moved to retirement sanctuaries unless that move would shorten their lives.